BCL2L1 and gastric cancer: Khanna et al. reported that GRAMD1B knockdown decreases STAT3 activation and expression of the anti-apoptotic factor Bcl-xL, thereby causing reduced growth and increased apoptosis induction in gastric cancer [43], which matches our observations in TNBC.